Hanna, John Gordon

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Hanna, John Gordon's trades of HLS Therapeutics Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
189.13
Quantity 60,861 -37.0%
Value CA$3,132,828
Transaction date
Purchase
Price
346.04
Quantity 85,477 +44.2%
Value CA$580,531
Transaction date
Purchase
Price
267.03
Quantity 7,006 +18.3%
Value CA$3,980,944
Transaction date
Purchase
Price
3.19
Quantity 2,800 +70.0%
Value CA$8,932
Transaction date
Purchase
Price
4.50
Quantity 4,000
Value CA$18,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-08 2026-09-01 B Purchase
60,861 -37.0%
189.13
CA$3,132,828
60,861 -37.0% 189.13 CA$3,132,828
2026-06-17 2026-06-16 B Purchase
85,477 +44.2%
346.04
CA$580,531
85,477 +44.2% 346.04 CA$580,531
2024-08-14 2024-08-14 B Purchase
7,006 +18.3%
267.03
CA$3,980,944
7,006 +18.3% 267.03 CA$3,980,944
2024-08-14 2024-08-13 B Purchase
2,800 +70.0%
3.19
CA$8,932
2,800 +70.0% 3.19 CA$8,932
2023-08-29 2023-08-25 B Purchase
4,000
4.50
CA$18,000
4,000 4.50 CA$18,000